We are developing a next generation test to assess patients with chest pain.
LightDeck Cardiac Panel
We are developing a 3-plex test with high-sensitivity troponin, NT-proBNP and D-dimer. The LightDeck Cardiac Panel will deliver actionable results in 15 minutes.
Enables faster diagnosis of heart attack or rule-out/discharge of low-risk patients.
Assess patients with shortness of breath or chest pain for heart failure.
Pulmonary embolism (PE) presents as shortness of breath, a symptom common with heart attack and heart failure.
We are developing a next generation test to assess patients with chest pain: a high-sensitivity troponin test that will enable faster diagnosis of heart attack or rule-out/discharge of low-risk patients. Safe discharge reduces unnecessary hospital admissions, reduces crowding in the emergency department and cuts costs to the healthcare system significantly.
Emergency physicians need sensitive, precise lab results to guide treatment or safe discharge for patients with chest pain. Professional guidelines are driving the shift to high-sensitivity troponin assays, which can diagnose or rule-out heart attack 4 to 6 hours earlier than contemporary troponin tests.
NT-proBNP and D-Dimer
Patients with heart failure or pulmonary embolism (PE) often have symptoms that are common with heart attack: chest pain and/or shortness of breath. Heart failure is a condition where the heart does not pump blood efficiently. Approximately 6.2 million Americans have heart failure. There are 1 million new cases diagnosed and over 78,000 deaths annually. PE is a life-threating blood clot in the lung. The LightDeck Cardiac Panel is a 3-plex panel to help differentiate between a heart attack (high-sensitivity troponin), heart failure (NT-proBNP) and PE (D-dimer).
Partner with us
Contact us to learn more about our cardiac markers program.